Sulfadiazine 167 mg / sulfamerazine 167 mg / sulfamethazine 167 mg Oral Tablet [Triple Sulfa No. 2]
RxNorm 540938

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 540938 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: sulfadiazine 167 mg / sulfamerazine 167 mg / sulfamethazine 167 mg Oral Tablet [Triple Sulfa No. 2].

The following semantic concepts and normalized strings are associated with this clinical entity:

SBD
Sulfadiazine 167 mg / sulfamerazine 167 mg / sulfamethazine 167 mg Oral Tablet [Triple Sulfa No. 2]
AUI:12364790
View
TMSY
SulfADIAZINE 167 mg / sulfamerazine 167 mg / sulfamethazine 167 mg Oral Tablet [Triple Sulfa No. 2]
AUI:12381882
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SBD

Semantic Branded Drug (SBD):
Sulfadiazine 167 mg / sulfamerazine 167 mg / sulfamethazine 167 mg Oral Tablet [Triple Sulfa No. 2]
(Atom ID: 12364790)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
sulfadiazine 167 MG / sulfamerazine 167 MG / sulfamethazine 167 MG Oral Tablet [Triple Sulfa No. 2]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
540938
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12364790
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
540938
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN OBSOLETED
04/30/2020
Date the RxNorm atom became obsolete
RXTERM FORM
Tab
The RxTerm dose form name for this drug
TMSY

Tall Man Lettering Synonym (TMSY):
SulfADIAZINE 167 mg / sulfamerazine 167 mg / sulfamethazine 167 mg Oral Tablet [Triple Sulfa No. 2]
(Atom ID: 12381882)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
sulfADIAZINE 167 MG / sulfamerazine 167 MG / sulfamethazine 167 MG Oral Tablet [Triple Sulfa No. 2]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
540938
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12381882
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
TMSY
Tall Man Lettering Synonym (Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.)
Source Code
540938
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.